Advertisement
Article tools
  • View PDF
  • Cite this article
  • E-mail this article
  • Send a letter
  • Information on reuse
  • Standard abbreviations
  • Article usage
Author information
Need help?

Commentary

Fibulin-5: two for the price of one maintaining pelvic support

Gina M. Northington

Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Address correspondence to: Gina M. Northington, Department of Obstetrics and Gynecology, Division of Urogynecology and Reconstructive Pelvic Surgery, The Hospital of the University of Pennsylvania, 3400 Spruce St., 1000 Ravdin Courtyard, Philadelphia, Pennsylvania 19104, USA. Phone: 215.662.6361; Fax: 215.662.7929; E-mail: gnorthington@obgyn.upenn.edu.

First published April 25, 2011

Pelvic organ prolapse (POP) is a disabling disorder in women characterized by a loss of pelvic floor support leading to the herniation of the uterus into or through the vagina. POP is a complex problem that likely involves multiple mechanisms, and available therapies are limited. In this issue of the JCI, Budatha et al. explore the dual role carried out by fibulin-5 in facilitating the assembly of normal elastic fibers and inhibiting MMP-9 activity, revealing a new mechanism critical to the maintenance of pelvic organ support.

See the related article beginning on page 2048.

Pelvic organ prolapse (POP) is a major cause of morbidity among women in the United States. It occurs in approximately 35% of the adult female population, and the incidence increases with age (1). The impact of POP on women is significant, including sexual dysfunction, social isolation, depression, and poor body image (2). The etiology is multifactorial, with a history of vaginal childbirth being the most notable risk factor (3, 4). It is estimated that 11%–19% of women will require surgical repair in their lifetime to treat prolapse, and approximately one-third of these will require additional surgery for recurrent disease (5); thus it is important to define the molecular and cellular mechanisms of POP. Because of the difficulty of procuring human tissue and the expense associated with studying POP in primates (6), rodent models of elastinopathies have been used to study this disease (79). While rodents are quadrupeds and, by definition, have different forces operating on the pelvic floor, the connective tissue anatomy is grossly similar to that seen in humans (10). Although pelvic floor injury is recognized as a common antecedent to the development of POP, an improved understanding of the subsequent cellular and genetic alterations in connective tissue is required to improve therapeutic strategies. In this issue of the JCI, Budatha et al. (11) exploit murine genetic models to develop a unifying molecular mechanism of abnormal elastic fiber homeostasis leading to POP and identify fibulin-5 as the central player in the pathophysiology of this disorder (12).

Elastinopathy in pelvic organ prolapse

Because women suffering from connective tissue disorders such as Marfan or Ehlers-Danlos syndromes have high rates of spontaneous pelvic organ prolapse (13), considerable interest has been directed at understanding alterations in connective tissue homeostasis that contribute to the etiology of prolapse. The pelvic floor is supported by an ECM composed of collagen, elastic fibers, and proteoglycans, and several published reports associate POP with changes in these ECM components and in the activity of MMPs (1416).

MMPs play an important role in tissue remodeling and collectively form a 26-member family of proteases that are mainly responsible for proteolytic degradation of the ECM proteins, including collagens, gelatins, and elastin. Although degradation has been shown to be an important part of MMP function, recent data suggest that MMPs can also affect cellular growth and behavior through the interaction between MMP substrates with ECM-independent factors, including growth factors, cytokines, adhesion receptors, and cell surface proteoglycans (17). Previous studies have identified MMP-2 and -9 as the primary elastolytic enzymes involved in the pathogenesis of POP (3). Utilizing zymography, Jackson et al. demonstrated increased active MMP-2 and -9 in women with POP compared with controls (14). Other groups have demonstrated a similar increase in the active form of MMP-9 in association with POP (3). Interestingly, an increase in MMP-9 activity does not necessarily correspond to an increased transcript level in prolapsed vaginal tissue, suggesting that posttranscriptional regulation of MMP-9 occurs in POP (15). Taken together, these data signify that increased ECM turnover is an essential process in this disorder.

While mature, insoluble elastin is generally stable after development throughout the life span (18), elastic fibers in the female reproductive tract undergo frequent turnover under normal physiologic conditions. Elastin is an insoluble and durable cross-linked array synthesized by joining soluble tropoelastin protein molecules in a reaction catalyzed by lysyl oxidase (LOX) (Figure 1) and provides expansion and recoil in response to tension, which supports the pelvic floor during parturition. Elastic fibers normally degrade during labor and are resynthesized following vaginal delivery (19); this process is under hormonal control and is mediated by age (20). Wieslander et al. (19) demonstrated increased MMP-2 and MMP-9 enzyme activities with a corresponding decrease in protease inhibitors (TIMP2, cystatin C, and α-1 antitrypsin) in genetically normal mice 48 hours after delivery of pups. It is theorized that abnormalities in this normal process of degradation and renewal could lead to POP as women age.

Model of elastogenesis.Figure 1

Model of elastogenesis.N-terminal region of LOXL1 binds to C-terminal domain of fibulin-5 to activate tropoelastin by converting to lysyl-deaminated form. Covalent cross-linking of tropoelastin occurs to form mature elastin. There are additional regulatory processes in elastogenesis that are tissue specific.

Murine models of POP

LOXs are a family of five enzymes that catalyze the cross-linking of collagen and elastin (21). LOX-like 1 protein (LOXL1) appears to be the most important factor in vaginal tissue remodeling that occurs after parturition and in POP associated with aging (20). LOXL1-knockout mice (Loxl1–/–) demonstrate multiple elastinopathies early in life but do not develop spontaneous POP until after 12 weeks of age or delivery of first and second litters (7). Loxl1–/– mice have significantly lower vaginal elastin content and, together with absent normal fluctuations in LOXL1 throughout pregnancy and parturition, this leads to abnormal renewal of the ECM following delivery compared with WT animals (7). These studies suggest that synthesis and degradation of elastic fibers both play a role in vaginal wall remodeling.

Another family of proteins important in elastic fiber matrix assembly and function are fibulins. Fibulins are secreted glycoproteins that become incorporated into a fibrillar extracellular matrix. The seven known members of the fibulin family (fibulins 1–7) have a series of EGF-like domains followed by a C-terminal “fibulin-type” domain (22). Both fibulin-3 and fibulin-5 have been implicated as having a role in maintaining pelvic support (8, 9). Fibulin-3–knockout mice (Fbln3–/–) have abdominal wall fascial defects and variably develop POP that increases with age. Moreover, the Fbln3–/– animals that exhibit POP also have increased levels of active MMP-2 and MMP-9 compared with Fbln3–/– animals without prolapse or WT animals (9). However, these animals experience normal tissue recovery following parturition. This latter finding could be related to the observed compensatory increase in mRNA transcripts for protease inhibitors (TIMP1, TIMP3), fibulin-5, and tropoelastin (9).

Fibulin-5–knockout mice (Fbln5–/–) consistently develop prolapse with advancing age: 91% of Fbln5–/– animals develop POP by 6 months of age, while this is true of only 50% and 27% of older Loxl1–/– and Fbln3–/– animals, respectively (79). Additionally, increased monocytic infiltration in the vaginal wall during labor seen in Fbln5–/– animals may indicate increased elastolytic activity, further suggesting that both abnormal synthesis and increased degradation are necessary to develop POP (8). Given the aforementioned findings in both Fbln5–/– and Loxl1–/– animals, Budatha et al. sought to further explain the interactions between fibulin-5 and LOXL1 in the pathogenesis of POP (11).

Fibulin-5 promotes cell adhesion by interacting with integrins via its RGD motif. Budatha et al. generated mice homozygous for alleles of Fbln5 in which the RGD motif was mutated (Fbln5RGE) and found that these mice had elastic fibers and ECM protein content that was comparable to that of WT animals (11). In contrast to the Fbln5–/– animals, POP was not observed in the Fbln5RGE/RGE animals after pregnancy or with advancing age, suggesting that integrin-binding activity of fibulin-5 does not affect normal elastic fiber formation (Figure 2). The authors further demonstrated a significant increase in MMP-9 activity in vaginal tissues from the Fbln5RGE/RGE and Fbln5–/– animals compared with WT. They determined that fibulin 5 indirectly mediates the upregulation of MMP-9 in an RGD-dependent manner. ROS also upregulate MMP-9 in vaginal stromal cells from both fibulin mutant mouse models, suggesting that the fibulin-5 integrin interaction is a mediator in the pathway between ROS and MMP-9 activity in the vaginal wall (Figure 2).

Role of Fibulin 5 in POP.Figure 2

Role of Fibulin 5 in POP.(A) In Fbln5+/+ (WT) mice, there is normal elastic fiber synthesis. Fbln5 interacts with integrin, inhibiting MMP-9. (B) In Fbln5RGE/RGE animals, there is normal elastic fiber formation and increased MMP-9 activity. Similar to the WT, POP does not develop in these animals. (C) Fbln5–/– animals develop abnormal elastic fibers, increased ROS, and increased MMP-9 activity. POP develops in 96% of Fbln5–/– animals. (D) Fbln5–/–MMP-9–/– (DKO) animals have abnormal elastic fibers. Only 40% of animals developed POP, suggesting the importance of both abnormal elastic fiber synthesis and increased MMP-9 activity in development of this disease.

What is most interesting about this study is that, although Fbln5RGE/RGE mice do not appear to develop POP or abnormal elastic fiber assembly, they do develop a milder form of disease when LOX activity is blocked by treating animals with β-aminopropionitrile (BAPN). If this is due to impaired de novo elastin synthesis, as the authors suggest, it would be interesting to see whether more severe POP develops in animals treated with BAPN for longer periods of time. To further demonstrate the necessity of both MMP-9 activity and abnormal elastic fiber synthesis for POP, Budatha et al. generated mice that were deficient in both MMP-9 and fibulin-5 to form a double KO (DKO) model (11). Only 42% of the DKO mice developed POP, while 95% of the Fbln5–/– animals developed the disorder, strengthening the argument that MMP-9 upregulation accounts for a significant part of the pelvic floor dysfunction in Fbln5–/– mice.

Concluding remarks

There is increasing evidence that POP results from alterations in the relative balance between synthesis and degradation of the ECM in pelvic tissues. In this paper, Budatha et al. have elegantly established a dual role for fibulin-5 in the regulation of elastic fiber homeostasis (11). They demonstrate that fibulin-5 not only facilitates the normal assembly of elastic fibers, but also inhibits MMP-9 through RGD-dependent integrin-binding. In addition, they provide evidence that both abnormal elastic fibers and upregulation of MMP-9 are necessary and sufficient for the full manifestation of POP in murine models.

Although these results have generated important information about the elastinopathic pathways involved in POP, several questions remain. It is still not known how hormonal and aging mechanisms have an impact on these pathways. This is highlighted by the human studies included in this paper. The researchers demonstrated that although MMP-9 was significantly increased in women with prolapse compared with controls, the difference among postmenopausal women (prolapse vs. control) was a large 23-fold change while, among the premenopausal women, there was only a modest 3-fold change. These results, and those of other groups (3), suggest that hormonal modulation is an important factor and should be considered in all molecular pathways that lead to POP.

Other human studies have suggested that alterations in genes responsible for elastic fiber homeostasis are more common in women with clinical manifestations of POP (23), and family history is a known risk factor for the development of this disease (24). It would be important to understand how genetic susceptibility plays into the elastinopathic pathways identified in murine models. Further research is needed to phenotype individuals to determine who is at risk for developing POP primarily or to identify those at risk of recurrence after standard therapies.

Acknowledgments

The author’s work is supported by the Women’s Reproductive Health Research Award NIH/National Institute of Child Health and Human Development (K12- HD00165-11).

Footnotes

Conflict of interest: The author has declared that no conflict of interest exists.

Citation for this article:J Clin Invest. 2011;121(5):1688–1691. doi:10.1172/JCI57438

See the related article beginning on page 2048.

References

  1. Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol. 2008;111(3):678–685.
    View this article via: PubMed CrossRef
  2. Lowder JL, Ghetti C, Nikolajski C, Oliphant SS, Zyczynski HM. Body image perceptions in women with pelvic organ prolapse: a qualitative study [published online ahead of print February 1, 2011]. Am J Obstet Gynecol.doi:10.1016/j.ajog.2010.12.024.
    View this article via: PubMed
  3. Word RA, Pathi S, Schaffer JI. Pathophysiology of pelvic organ prolapse. Obstet Gynecol Clin North Am. 2009;36(3):521–539.
    View this article via: PubMed CrossRef
  4. Lukacz ES, Lawrence JM, Contreras R, Nager CW, Luber KM. Parity, mode of delivery, and pelvic floor disorders. Obstet Gynecol. 2006;107(6):1253–1260.
    View this article via: PubMed CrossRef
  5. Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010;116(5):1096–1100.
    View this article via: PubMed CrossRef
  6. Mattson JA, Kuehl TJ, Yandell PM, Pierce LM, Coates KW. Evaluation of the aged female baboon as a model of pelvic organ prolapse and pelvic reconstructive surgery. Am J Obstet Gynecol. 2005;192(5):1395–1398.
    View this article via: PubMed CrossRef
  7. Liu X, Zhao Y, Pawlyk B, Damaser M, Li T. Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am J Pathol. 2006;168(2):519–528.
    View this article via: PubMed CrossRef
  8. Drewes PG, et al. Pelvic organ prolapse in fibulin-5 knockout mice: pregnancy-induced changes in elastic fiber homeostasis in mouse vagina. Am J Pathol. 2007;170(2):578–589.
    View this article via: PubMed CrossRef
  9. Rahn DD, et al. Failure of pelvic organ support in mice deficient in fibulin-3. Am J Pathol. 2009;174(1):206–215.
    View this article via: PubMed CrossRef
  10. Moalli PA, et al. A rat model to study the structural properties of the vagina and its supportive tissues. Am J Obstet Gynecol. 2005;192(1):80–88.
    View this article via: PubMed CrossRef
  11. Budatha M, et al. Extracellular matrix proteases contribute to progression of pelvic organ prolapse in mice and humans. J Clin Invest. 2011;121(5):2048–2059.
    View this article via: JCI.org
  12. Yanagisawa H, Schluterman MK, Brekken RA. Fibulin-5, an integrin-binding matricellular protein: its function in development and disease. J Cell Commun Signal. 2009;3(3–4):337–347.
    View this article via: PubMed CrossRef
  13. Carley ME, Schaffer J. Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers Danlos syndrome. Am J Obstet Gynecol. 2000;182(5):1021–1023.
    View this article via: PubMed CrossRef
  14. Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genitourinary prolapse. Lancet. 1996;347(9016):1658–1661.
    View this article via: PubMed CrossRef
  15. Chen BH, Wen Y, Li H, Polan ML. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(2):80–87.
    View this article via: PubMed CrossRef
  16. Moalli PA, Shand SH, Zyczynski HM, Gordy SC, Meyn LA. Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol. 2005;106(5 pt 1):953–963.
    View this article via: PubMed
  17. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol. 2003;200(4):448–464.
    View this article via: PubMed CrossRef
  18. Mecham RP, Davis EC. Elastic fiber structure and assembly. In: Yurchenko PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure . San Diego, California, USA: Academic Press; 1994:281–314.
  19. Wieslander CK, Marinis SI, Drewes PG, Keller PW, Acevedo JF, Word RA. Regulation of elastolytic proteases in the mouse vagina during pregnancy, parturition, and puerperium. Biol Reprod. 2008;78(3):521–528.
    View this article via: PubMed CrossRef
  20. Liu X, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36(2):178–182.
    View this article via: PubMed CrossRef
  21. Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003;88(4):660–672.
    View this article via: PubMed CrossRef
  22. Argraves WS, Greene LM, Cooley MA, Gallagher WM. Fibulins: physiological and disease perspectives. EMBO Rep. 2003;4(12):1127–1131.
    View this article via: PubMed CrossRef
  23. Chen HY, Lin WY, Chen YH, Chen WC, Tsai FJ, Tsai CH. Matrix metalloproteinase-9 polymorphism and risk of pelvic organ prolapse in Taiwanese women. Eur J Obstet Gynecol Reprod Biol. 2010;149(2):222–224.
    View this article via: PubMed CrossRef
  24. McLennan MT, Harris JK, Kariuki B, Meyer S. Family history as a risk factor for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(8):1063–1069.
    View this article via: PubMed
Advertisement
Advertisement